Assignee
PINTEX PHARMACEUTICALS INC
US·2 granted patents·10 pending applications·9 citations·filing 2002–2006
Top patents by PatentIndex Score
12 records- 0177US7592145B2Pin 1 as a marker for prostate cancerPINTEX PHARMACEUTICALS INC·Filed 2006·Granted Sep 22, 2009·9 cites·8 claims
- 0249US2005004024A1Methods of treating Pin1 associated disorders by covalent modification of active site residuesPINTEX PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 0347US2006106077A1Pin1-Modulating compounds and methods of use thereofPINTEX PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 0442US2005049267A1Pin1-modulating compounds and methods of use thereofPINTEX PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 0542US2004214872A1Pin1-modulating compounds and methods of use thereofPINTEX PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 0639US2004176277A1Methods of treating Pin1 associated disordersPINTEX PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 0739US2004176912A1Methods for designing specific inhibitors for Pin1 proline isomerase and Pin1-related moleculesPINTEX PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 0838US2003073096A1Pin1 as a marker for prostate cancerPINTEX PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 0935US2004176372A1Pin1-modulating compounds and methods of use thereofPINTEX PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 1034US7501255B2Levels of Pin1 in normal and cancerous tissuePINTEX PHARMACEUTICALS INC·Filed 2003·Granted Mar 10, 2009·0 cites·14 claims
- 1133US2003068626A1Pin1 as a marker for abnormal cell growthPINTEX PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 1227US2004180889A1Pin1-modulating compounds and methods of use thereofPINTEX PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →